Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $98,238 | 55 | 78.8% |
| Travel and Lodging | $14,482 | 30 | 11.6% |
| Food and Beverage | $11,935 | 455 | 9.6% |
| Education | $10.52 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $118,070 | 214 | $0 (2024) |
| ABBVIE INC. | $763.85 | 38 | $0 (2024) |
| Daiichi Sankyo Inc. | $696.02 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $434.94 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $417.47 | 21 | $0 (2024) |
| Mannkind Corporation | $382.86 | 20 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $381.26 | 26 | $0 (2024) |
| Lilly USA, LLC | $260.96 | 13 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $232.90 | 10 | $0 (2017) |
| PFIZER INC. | $217.28 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,743 | 78 | Amgen Inc. ($17,570) |
| 2023 | $76,246 | 121 | Amgen Inc. ($75,416) |
| 2022 | $24,206 | 63 | Amgen Inc. ($23,532) |
| 2021 | $1,301 | 67 | AbbVie Inc. ($247.27) |
| 2020 | $743.37 | 36 | Amgen Inc. ($247.77) |
| 2019 | $1,019 | 51 | Amgen Inc. ($416.77) |
| 2018 | $1,148 | 65 | Amgen Inc. ($278.23) |
| 2017 | $1,259 | 60 | Amgen Inc. ($386.56) |
All Payment Transactions
541 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/09/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Genetic Disease | ||||||
| 11/25/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $484.12 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $142.16 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $22.87 | General |
| Category: Coronary | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Oncology | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 2,836 | 3,977 | $224,178 | $115,883 |
| 2022 | 41 | 2,642 | 3,754 | $211,861 | $105,746 |
| 2021 | 38 | 2,646 | 3,712 | $223,933 | $107,320 |
| 2020 | 41 | 2,644 | 3,749 | $220,779 | $106,699 |
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 140 | 304 | $74,000 | $43,186 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 156 | $29,310 | $15,780 | 53.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 44 | 46 | $12,304 | $6,427 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 79 | $9,159 | $5,802 | 63.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 61 | 63 | $8,838 | $4,712 | 53.3% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 64 | 65 | $11,492 | $4,643 | 40.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 123 | 173 | $5,830 | $2,848 | 48.8% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2023 | 132 | 216 | $9,060 | $2,741 | 30.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 128 | 196 | $4,188 | $2,572 | 61.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 148 | 292 | $3,140 | $2,322 | 73.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 91 | 107 | $4,350 | $2,164 | 49.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 25 | $2,500 | $1,795 | 71.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 107 | 120 | $4,401 | $1,774 | 40.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 131 | 232 | $4,188 | $1,766 | 42.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 96 | 112 | $3,410 | $1,298 | 38.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 108 | 154 | $8,224 | $1,277 | 15.5% |
| 80076 | Liver function blood test panel | Office | 2023 | 107 | 148 | $2,192 | $1,185 | 54.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 58 | 82 | $2,265 | $1,096 | 48.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 51 | 60 | $1,802 | $1,081 | 60.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 34 | 37 | $2,187 | $1,073 | 49.1% |
| 83735 | Magnesium level | Office | 2023 | 105 | 145 | $2,582 | $952.65 | 36.9% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 105 | 129 | $1,799 | $823.02 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 25 | $855.00 | $819.42 | 95.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 88 | 91 | $1,745 | $804.44 | 46.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 18 | $1,110 | $799.71 | 72.0% |
About Dr. Robert Huizenga, M.D
Dr. Robert Huizenga, M.D is a Internal Medicine healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245264720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Huizenga, M.D has received a total of $124,665 in payments from pharmaceutical and medical device companies, with $18,743 received in 2024. These payments were reported across 541 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($98,238).
As a Medicare-enrolled provider, Huizenga has provided services to 10,768 Medicare beneficiaries, totaling 15,192 services with total Medicare billing of $435,647. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Beverly Hills, CA
- Active Since 07/10/2006
- Last Updated 08/03/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245264720
Products in Payments
- Repatha (Biological) $116,885
- INJECTAFER (Drug) $696.02
- XIFAXAN (Drug) $532.22
- Otezla (Drug) $419.09
- Aimovig (Biological) $407.15
- AFREZZA (Drug) $382.86
- UBRELVY (Drug) $286.92
- ENTRESTO (Drug) $229.18
- Prolia (Biological) $216.60
- LEQVIO (Drug) $205.76
- LINZESS (Drug) $192.90
- Thyquidity (Drug) $145.08
- AJOVY (Drug) $138.93
- SHINGRIX (Biological) $138.44
- GARDASIL (Biological) $128.85
- Trintellix (Drug) $126.94
- CHANTIX (Drug) $126.88
- Truvada (Drug) $124.91
- XARELTO (Drug) $119.16
- STELARA (Biological) $118.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Beverly Hills
Dr. Pedram Enayati, M.d, M.D
Internal Medicine — Payments: $331,655
Jeremy Lorber, Md, MD
Internal Medicine — Payments: $267,125
Dr. Christine Lee, Md, MD
Internal Medicine — Payments: $257,687
Eldad Einav, M.d, M.D
Internal Medicine — Payments: $195,664
Peyton Berookim, M.d, M.D
Internal Medicine — Payments: $124,403
David Weissman, Md, MD
Internal Medicine — Payments: $77,892